Target & Activity
| Target | Activity | Value |
|---|---|---|
| Akt | N/A | |
| PI3K | ||
| PKC | ~7 μM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| 786-0 | IC50 | > 100 μM | Cytotoxicity against human 786-O cells assessed as decrease in mitochondrial viability after 6 hrs by CMXRos staining based assay | [PMID: 29407968] |
| A2780 | IC50 | 8.87 μM | Cytotoxicity against human A2780 cells after 24 hrs by MTT method | [PMID: 25698517] |
| A-431 | IC50 | 12 μM | Cytotoxic activity against human A431 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay | [PMID: 25814031] |
| A-431 | IC50 | 53.7 μM | Cytotoxicity against human A431 cells after 24 hrs by MTT assay | [PMID: 20039643] |
| A549 | IC50 | > 100 μM | Cytotoxicity against human A549 cells after 48 hrs by CellTiter-Glo assay | [PMID: 29407968] |
| A549 | IC50 | 44.7 μM | Cytotoxicity against human A549 cells after 72 hrs by MTT assay | [PMID: 19762125] |
| A549 | IC50 | 8.5 μM | Cytotoxic activity against human A549 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay | [PMID: 25814031] |
| A549 | IC50 | 8.6 μM | Cytotoxicity against human A549 cells after 72 hrs by MTT assay | [PMID: 23792315] |
| A549 | IC50 | 9.6 μM | Inhibition of Akt phosphorylation in insulin-stimulated human A549 cells treated 2 hrs before insulin stimulation measured after 30 mins by ELISA | [PMID: 22138309] |
| A549 | IC50 | 9.6 μM | Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA | [PMID: 23415083] |
| A549 | IC50 | 9.7 μM | Cytotoxicity against human A549 cells after 24 hrs by FACS analysis | [PMID: 22138309] |
| A549 | IC50 | 9.7 μM | Cytotoxicity against human A549 cells by flow cytometric analysis | [PMID: 23415083] |
| BJ | IC50 | > 50 μM | Cytotoxicity against human BJ cells after 24 hrs by redox-sensitive dye based fluorescent assay | [PMID: 33091607] |
| BMDM | IC50 | ≥ 200 μM | Cytotoxicity against mouse BMDM after 96 hrs by MTT assay | [PMID: 23719286] |
| CCRF-CEM | IC50 | 13.5 μM | Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay | [PMID: 19762125] |
| CCRF-CEM | IC50 | 20.7 μM | Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay | [PMID: 23792315] |
| DU-145 | IC50 | 24.92 μM | In vitro cytotoxic activity against prostate carcinoma (DU-145) cells assayed by inhibition of [3H]-labeled thymidine incorporation | [PMID: 11728191] |
| DU-145 | IC50 | 25.78 μM | Antiproliferative activity against human DU145 cells assessed as inhibition of cell proliferation incubated for 18 hrs followed by MTT addition for 4 hrs by MTT assay | [PMID: 25128666] |
| Erythrocyte | EC50 | 30 μM | Toxicity in human erythrocytes assessed as hemolysis after 1 hr | [PMID: 19762125] |
| HeLa | IC50 | 16.5 μM | Cytotoxic activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay | [PMID: 25814031] |
20 records · Scroll to view more